OQS
IRMD icon

Occudo Quantitative Strategies’s iRadimed IRMD Stock Holding History

Occudo Quantitative Strategies’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$394K Buy
+4,722
New +$472K 0.02% 534
2025
Q2 		– Sell
-4,550
Closed -$238K – 767
2025
Q1 		$238K Buy
+4,550
New +$256K 0.03% 525
2024
Q1 		– Sell
-4,259
Closed -$202K – 890
2023
Q4 		$202K Buy
+4,259
New +$179K 0.03% 647
2023
Q3 		– Sell
-4,602
Closed -$220K – 1133
2023
Q2 		$220K Buy
+4,602
New +$208K 0.02% 824

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Occudo Quantitative Strategies's IRMD Position: Q1 2026 in Review

Occudo Quantitative Strategies opened a new position in iRadimed (IRMD) in Q1 2026: 4,722 shares worth $394K. The stake represents 0.02% of the portfolio and ranks #534 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in IRMD as recently as Q1 2025.

Occudo Quantitative Strategies first reported a position in IRMD in Q2 2023 and has held it in 4 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Occudo Quantitative Strategies held 4,722 shares of iRadimed worth $394K as of Q1 2026.
  • iRadimed was a new Occudo Quantitative Strategies position in Q1 2026.
  • iRadimed made up 0.02% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #534 holding.
  • Occudo Quantitative Strategies first reported a position in iRadimed in Q2 2023 and has held it in 4 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.